#carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

Limit the spread. Improve the Outcome.

Every time a microorganism becomes resistant to an antibiotic, we lose another vital weapon in the war against infection. Newly resistant microorganisms are emerging—and spreading globally—every day. The result: antimicrobial resistance (AMR). In the very near future, we may be left without any drugs at all to fight serious, resistant infections.¹

AMR leads to longer hospital stays, increased mortality, and higher medical costs.

2 Million
The annual number of patients with AMR infections in the U.S.²

$39 Million
Extra healthcare costs and productivity losses in the U.S. per year due to AMR²

23,000
The annual number of deaths in the U.S. caused by AMR²

#carousel-content-2 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-2 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

VIDEO

What is "The Antibiotic Apocalypse"?

The Antibiotic Apocalypse. It’s more dangerous than we thought.

Watch Video

Better Antibiotic Stewardship
with GeneXpert^®

When today’s healthcare providers are able to quickly identify whether an infection is present and if it is drug-resistant, we will finally be able to move beyond trial and error. On-demand molecular diagnostics have the potential to help you identify resistance in minutes, rather than days. Cepheid’s GeneXpert^® System helps those on the frontlines of resistance prevent the inappropriate use of antimicrobials and preserve our antibiotic weapons―now and in the future. Click here to download our antimicrobial stewardship brochure.

Download Antibiotic Stewardship Brochure

Antimicrobial stewardship interventions with rapid molecular diagnostics:

	Shortened hospital length of stay by 2.5 days³
	Decreased lethal bloodstream infections in patients by 36%³
	Reduced time to effective therapy by 5 hours³

#carousel-content-4 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-4 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

VIDEO

Antibiotics "just-in-case" | Debbie Goff | TEDxColumbus

In a recent TEDx talk, Dr. Debbie Goff, a clinical pharmacist and global antimicrobial stewardship advocate, outlined a compelling case for shared accountability in the fight against drug-resistant organisms. With real-life examples of “just in case” antibiotic use, the case for stewardship is presented with impressive clarity and humanity.

Watch Video

VIDEO

Carbapenemases

Dr. Tim Neal, Infection Control Doctor at Liverpool Clinical Laboratories, details how rapid molecular diagnostic solutions are critical to staying ahead of the emerging threat of carbapenemase-producing Enterobacteriaceae (CPE).

Read the related white paper

Watch Video

Related White Papers & Webinars

#carousel-content-6 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-6 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

WEBINAR

Antibiotic Stewardship in the Emergency Department

This webinar discusses the importance of diligent antimicrobial stewardship and accuracy of diagnostic tests for the detection of Group A Streptococcus pharyngitis. It provides commentary on the high confidence that molecular testing affords the antibiotic steward and how technology can reduce the practice of prescribing antibiotics "just-in-case" there is an infection, especially as testing moves closer to the patient.

WEBINAR

RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs

This webinar discusses data supporting the combination of rapid diagnostic tests (RDT) and antimicrobial stewardship programs (ASPs), reviews RDT systems, and provides guidance on how ASPs can implement and optimize the use of RDTs in virtually any healthcare setting.

DOCUMENT

White Paper: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance

CDC has declared the complex problem of AMR a serious threat today, which will result in potential catastrophic consequences with continued inaction. To combat AMR, the CDC has identified 4 core actions, all of which can be addressed through rapid molecular diagnostics:

DOCUMENT

White Paper: Preventing "Nightmare Bacteria" from Becoming Nightmare Outbreaks

In early 2015, carbapenem-resistant Enterobacteriaceae (CRE) became a household term when a high-profile outbreak — including two deaths — at a California hospital were linked to contaminated medical scopes.

Related Product Links

#carousel-content-7 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-7 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }